32nd Annual Meeting of the American College of Toxicology November 6, 2011

The 32nd Annual Meeting of the American College of Toxicology aims to promote the exchange of information and perspectives on the current status of safety assessment and the application of new developments in toxicology. The event will include continuing education courses, a series of plenary sessions and poster sessions, and the annual ACT Awards ceremony.

Scott Manetz will present “Afucosylated anti-IL-5 receptor alpha antibody (benralizumab): nine month chronic toxicology study in sexually mature cynomolgus monkeys.”